| Name | Title | Contact Details |
|---|
The largest health insurer in the state of Kansas. As a mutual insurance company, BCBSKS is owned by its policyholders. Its board of directors consists of Kansans from different areas of the state, 16 policyholders who bring to the table practical experience in business, medicine, hospital administration and education. Day-to-day operations are directed by a nine-person steering committee under the guidance of the company’s president/CEO. Customers and health care professionals have a voice in company activities through numerous advisory and liaison committees, as well as focus groups and surveys. BCBSKS is a financially secure, billion dollar company that contributes to the Kansas economy in several ways. The company surpasses $1 billion in annual claims payments to health care providers and members and contributes more than $140 million a year to the economy through payroll and taxes. The company's headquarters are located in Topeka, KS. Nearly 1,400 employees work in the company's various office locations in Topeka. In addition, about 110 employees work in offices in Dodge City, Garden City, Hays, Hutchinson, Independence, Lawrence, Manhattan, Pittsburg, Salina and Wichita. BCBSKS is a member of the Blue Cross Blue Shield Association headquartered in Chicago. There are 36 Blue Cross and Blue Shield Plans throughout the United States. Each Plan is separate and independent but all Plans cooperate with other Blue Cross and Blue Shield Plans in the exchange of ideas, processing of claims and providing inter-plan services to customers.
Welch Allyn Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Skaneateles Falls, NY. To find more information about Welch Allyn Inc., please visit www.welchallyn.com
SummitHMR is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bowers Companies is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AveXis is a clinic-ready, synthetic biology platform company. AveXis has, at its core, a desire to establish unique industry and research alliances which will bring innovative treatments to people with unmet medical needs. Our work in spinal muscular atrophy (SMA), a rare/orphan disease, is our first focus.